Risultati di ricerca
Repligen provides technology breakthroughs and scalable hardware, software and consumables workflow solutions for the development and manufacture of plasmid DNA, viral vectors, mRNA and new modalities such as whole cells, cultivated meat.
- Solutions Overview
ADVANCING BIOPROCESSING With a culture of innovation, and...
- Ultrafiltration/Diafiltration
Repligen solutions help overcome key challenges in UF/DF,...
- Fluid Management
Repligen offers innovative, designed-for-purpose storage and...
- COVID Solutions
Repligen is ready to partner to help fast-track the...
- Modalities Overview
Repligen solutions help overcome key challenges in the...
- Antibodies | Proteins
Repligen solutions help overcome key challenges in...
- mRNA
Repligen offers solutions that help overcome key challenges...
- pDNA
Repligen Solutions Increased yield. Optimized vector...
- Solutions Overview
Products. Whether you are in fed-batch, hybrid continuous or full continuous mode, or working with therapeutic proteins, gene therapy or vaccines, you can use leading edge solutions from Repligen to streamline your processes and cut your manufacturing costs.
Repligen is a bioprocessing-focused life sciences company bringing expertise and innovation to our customers since 1981. We are inspiring advances in bioprocessing through the development and commercialization of high-value products and flexible solutions that address critical steps in the production of biologic drugs.
Repligen is an American company devoted to the development and production of materials used in the manufacture of biological drugs. 2014 The company is based in Waltham, Massachusetts, 2014 and was incorporated in Delaware in 1981.
Our mission is to inspire advances in bioprocessing as a trusted partner in the production of biologic drugs that improve human health worldwide.
25 ago 2023 · Repligen Corporation. 31,119 followers. 5d. Even more capabilities, same small footprint: KrosFlo KTF + We’ve taken the advanced technological capabilities of our premium line of TFF systems ...
16 set 2021 · Proposed acquisition strengthens Repligen’s Proteins business. Adds a market leader in affinity ligand discovery and development and complements established partnership with Navigo GmbH. Strategically moves Repligen into affinity resin solutions for gene therapy.
